Literature DB >> 17896398

Effects of left ventricular unloading by Impella recover LP2.5 on coronary hemodynamics.

Maurice Remmelink1, Krischan D Sjauw, José P S Henriques, Robbert J de Winter, Karel T Koch, René J van der Schaaf, Marije M Vis, Jan G P Tijssen, Jan J Piek, Jan Baan.   

Abstract

OBJECTIVES: We studied the effects of LV unloading by the Impella on coronary hemodynamics by simultaneously measuring intracoronary pressure and flow and the derived parameters fractional flow reserve (FFR), coronary flow velocity reserve (CFVR), and coronary microvascular resistance (MR).
BACKGROUND: Patients with compromised left ventricular (LV) function undergoing high-risk percutaneous coronary intervention (PCI) may benefit from LV unloading. Limited information is available on the effects of LV unloading on coronary hemodynamics.
METHODS: Eleven patients (mean LV ejection fraction of 35 +/- 11%) underwent PCI during LV support by the LV unloading device (Impella Recover LP2.5). Intracoronary measurements were performed in a nonstenotic coronary artery after the PCI, before and after adenosine-induced hyperemia at four different support levels (0-2.5 L/min).
RESULTS: Aortic and coronary pressure increased with increasing support levels, whereas FFR remained unchanged. Baseline flow velocity remained unchanged, while hyperemic flow velocity and CFVR increased significantly with increasing support levels (61 +/- 24 to 72 +/- 27 cm/sec, P = 0.001 and 1.88 +/- 0.52 to 2.34 +/- 0.63, P < 0.001 respectively). The difference between baseline MR and hyperemic MR significantly increased with increasing support levels (1.28 +/- 1.32 to 1.89 +/- 1.43 mm Hg cm(-1) sec, P = 0.005).
CONCLUSIONS: Unloading of the LV by the Impella increased aortic and intracoronary pressure, hyperemic flow velocity and CFVR, and decreased MR. The Impella-induced increase in coronary flow, probably results from both an increased perfusion pressure and a decreased LV volume-related intramyocardial resistance. (c) 2007 Wiley-Liss, Inc.

Entities:  

Mesh:

Year:  2007        PMID: 17896398     DOI: 10.1002/ccd.21160

Source DB:  PubMed          Journal:  Catheter Cardiovasc Interv        ISSN: 1522-1946            Impact factor:   2.692


  43 in total

1.  Impella 2.5.

Authors:  Daniel H Raess; David M Weber
Journal:  J Cardiovasc Transl Res       Date:  2009-04-02       Impact factor: 4.132

Review 2.  Theoretical models for coronary vascular biomechanics: progress & challenges.

Authors:  Sarah L Waters; Jordi Alastruey; Daniel A Beard; Peter H M Bovendeerd; Peter F Davies; Girija Jayaraman; Oliver E Jensen; Jack Lee; Kim H Parker; Aleksander S Popel; Timothy W Secomb; Maria Siebes; Spencer J Sherwin; Rebecca J Shipley; Nicolas P Smith; Frans N van de Vosse
Journal:  Prog Biophys Mol Biol       Date:  2010-10-30       Impact factor: 3.667

3.  First Canadian experience with high-risk percutaneous coronary intervention with assistance of a percutaneously deployed left ventricular assist device.

Authors:  Jonas Eichhöfer; Mark Osten; Eric Horlick; Vladimír Dzavík
Journal:  Can J Cardiol       Date:  2008-11       Impact factor: 5.223

Review 4.  Percutaneous left ventricular assist devices during cardiogenic shock and high-risk percutaneous coronary interventions.

Authors:  Stéphane Cook; Stephan Windecker
Journal:  Curr Cardiol Rep       Date:  2009-09       Impact factor: 2.931

5.  Improvement of myocardial perfusion with a percutaneously inserted left ventricular assist device.

Authors:  Raed A Aqel; Fadi G Hage; Ami E Iskandrian
Journal:  J Nucl Cardiol       Date:  2009-08-15       Impact factor: 5.952

6.  Percutaneous left ventricular assist device in high risk percutaneous coronary intervention.

Authors:  Omar Kahaly; Konstantinos Dean Boudoulas
Journal:  J Thorac Dis       Date:  2016-03       Impact factor: 2.895

7.  Successful bridge to recovery using a microaxial blood pump in a patient with electrical storm and cardiogenic shock.

Authors:  A Henning; J Schreieck; R Riessen; M Gawaz; A E May
Journal:  Med Klin Intensivmed Notfmed       Date:  2011-10-29       Impact factor: 0.840

8.  The Impella Recover 2.5 and TandemHeart ventricular assist devices are safe and associated with equivalent clinical outcomes in patients undergoing high-risk percutaneous coronary intervention.

Authors:  Jason C Kovacic; Huy T Nguyen; Rucha Karajgikar; Samin K Sharma; Annapoorna S Kini
Journal:  Catheter Cardiovasc Interv       Date:  2013-04-08       Impact factor: 2.692

9.  Impella®: an updated meta-analysis of available data and future outlook on applications in cardiogenic shock.

Authors:  Bernhard Wernly; Alexander Lauten; Holger Thiele; Christian Jung
Journal:  Wien Klin Wochenschr       Date:  2020-01-16       Impact factor: 1.704

10.  Percutaneous Hemodynamic Support (Impella) in Patients with Advanced Heart Failure and/or Cardiogenic Shock Not Eligible to PROTECT II Trial.

Authors:  Wei Liu; Venkata Kishore Mukku; Syed Gilani; Ken Fujise; Alejandro Barbagelata
Journal:  Int J Angiol       Date:  2013-12
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.